Antipsychotic medicines reduce the risk of psychotic episodes – and they are recommended for long-term use by people with schizophrenia or recurrent psychosis. But the medicines can have such unpleasant side effects that people prescribed these drugs may want to reduce or to stop them.
In this podcast, Helen Saul, Editor in Chief of NIHR Evidence, speaks with Joanna Moncrieff, Professor of Critical and Social Psychiatry at University College London; and Rachel Upthegrove, Professor of Psychiatry and Youth Mental Health at the University of Birmingham. They discuss an NIHR trial in which people were supported to gradually reduce their antipsychotic treatment
Read a full transcript of the episode here.
The views and opinions expressed in this podcast are those of the host and guests and do not necessarily reflect those of the NIHR or the Department of Health and Social Care.
